摘要
背景:迟发性双相情感障碍(LOBD)是双相障碍(BD)的觉醒,在老年(>60)之前没有任何障碍历史。迟发性双相情感障碍往往是很难区分的退行性痴呆,如阿尔茨海默病(AD),由于合并症和常见的认知症状。此外,迟发性双相情感障碍率是由于人口老龄化增加。因为病症分享相关的炎症反应的病理生理特征,从血浆中提取的生物标志物是不能判别的,因此我们寻找的解剖特点与血液的生物标志物,允许精确的诊断预测高度相关。这可能揭示了一些光的基本生物学机制,导致一个或另一种疾病。此外,准确的诊断需要选择最佳的个性化治疗。目的:我们寻找白质的特点,与血浆生物标志物的相关性(炎症和营养),从阿尔茨海默病中识别迟发性双相情感障碍。材料:一个健康对照样本(HC)(N = 19),阿尔茨海默病患者(n = 35),和双相障碍患者(n = 24)被招募在阿拉瓦大学医院。在招聘时已获得血浆生物标志物。弥散加权(DWI)磁共振成像(MRI)得到的每个主题。方法:弥散加权进行预处理得到的扩散张量成像(DTI)数据,这是减少各向异性分数(FA)数据。在选择阶段,解剖特性发现各向异性分数特征量血浆生物标志物的局部稀疏的典型相关分析的最大相关(PSCCAN)。在分析阶段,我们采取的特征量投影系数作为分类特征,进行支持向量机(SVM)交叉验证得到每个生物效应的识别能力。约翰霍普金斯大学白质阿特拉斯是用来提供的检测特征,集群的解剖定位。结果:结果表明,氧化应激的生物标志物(丙二醛)提供了最好的分类性能(精度85%,F 86%,敏感性和特异性87%)在阿尔茨海默病和迟发性双相情感障碍的歧视。识别特征似乎是位于内囊后肢和优越的科罗娜啤酒石蒜。结论:它是支持读取和基于各向异性分数成像的血浆生物标志物相关的计算机解剖特征预测分类的手段广告对比诊断可行。此外,白质解剖特征定位提供一些新的途径来评估读取迟发性双相情感障碍微分病理生理学和阿尔茨海默病。
关键词: 老年痴呆症,躁郁症,解剖特征,各向异性分数。
Current Alzheimer Research
Title:Eigenanatomy on Fractional Anisotropy Imaging Provides White Matter Anatomical Features Discriminating Between Alzheimer’s Disease and Late Onset Bipolar Disorder
Volume: 13 Issue: 5
Author(s): Ariadna Besga, Darya Chyzhyk, Itxaso González-Ortega, Alexandre Savio, Borja Ayerdi, Jon Echeveste, Manuel Graña and Ana González-Pinto
Affiliation:
关键词: 老年痴呆症,躁郁症,解剖特征,各向异性分数。
摘要: Background: Late Onset Bipolar Disorder (LOBD) is the arousal of Bipolar Disorder (BD) at old age (>60) without any previous history of disorders. LOBD is often difficult to distinguish from degenerative dementias, such as Alzheimer Disease (AD), due to comorbidities and common cognitive symptoms. Moreover, LOBD prevalence is increasing due to population aging. Biomarkers extracted from blood plasma are not discriminant because both pathologies share pathophysiological features related to neuroinflammation, therefore we look for anatomical features highly correlated with blood biomarkers that allow accurate diagnosis prediction. This may shed some light on the basic biological mechanisms leading to one or another disease. Moreover, accurate diagnosis is needed to select the best personalized treatment. Objective: We look for white matter features which are correlated with blood plasma biomarkers (inflammatory and neurotrophic) discriminating LOBD from AD. Materials: A sample of healthy controls (HC) (n=19), AD patients (n=35), and BD patients (n=24) has been recruited at the Alava University Hospital. Plasma biomarkers have been obtained at recruitment time. Diffusion weighted (DWI) magnetic resonance imaging (MRI) are obtained for each subject. Methods: DWI is preprocessed to obtain diffusion tensor imaging (DTI) data, which is reduced to fractional anisotropy (FA) data. In the selection phase, eigenanatomy finds FA eigenvolumes maximally correlated with plasma biomarkers by partial sparse canonical correlation analysis (PSCCAN). In the analysis phase, we take the eigenvolume projection coefficients as the classification features, carrying out cross-validation of support vector machine (SVM) to obtain discrimination power of each biomarker effects. The John Hopkins Universtiy white matter atlas is used to provide anatomical localizations of the detected feature clusters. Results: Classification results show that one specific biomarker of oxidative stress (malondialdehyde MDA) gives the best classification performance ( accuracy 85%, F-score 86%, sensitivity, and specificity 87%, ) in the discrimination of AD and LOBD. Discriminating features appear to be localized in the posterior limb of the internal capsule and superior corona radiata. Conclusion: It is feasible to support contrast diagnosis among LOBD and AD by means of predictive classifiers based on eigenanatomy features computed from FA imaging correlated to plasma biomarkers. In addition, white matter eigenanatomy localizations offer some new avenues to assess the differential pathophysiology of LOBD and AD.
Export Options
About this article
Cite this article as:
Ariadna Besga, Darya Chyzhyk, Itxaso González-Ortega, Alexandre Savio, Borja Ayerdi, Jon Echeveste, Manuel Graña and Ana González-Pinto , Eigenanatomy on Fractional Anisotropy Imaging Provides White Matter Anatomical Features Discriminating Between Alzheimer’s Disease and Late Onset Bipolar Disorder, Current Alzheimer Research 2016; 13 (5) . https://dx.doi.org/10.2174/1567205013666151116125349
DOI https://dx.doi.org/10.2174/1567205013666151116125349 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Activity-Dependent Synapse Modulation and the Pathogenesis of Alzheimer Disease
Current Alzheimer Research Autoimmune (Auto-inflammatory) Syndrome Induced by Adjuvants (ASIA) – Animal Models as a Proof of Concept
Current Medicinal Chemistry Hydrolases in Organic Chemistry. Recent Achievements in the Synthesis of Pharmaceuticals
Current Organic Chemistry General Anesthetics in Brain Injury: Friends or Foes?
Current Pharmaceutical Design Paediatric Antiretroviral Drug Targets
Infectious Disorders - Drug Targets Multivariate Analysis of Magnetic Resonance Imaging Signals of the Human Brain
Current Topics in Medicinal Chemistry Lessons from Darwin: Evolutionary Biologys Implications for Alzheimers Disease Research and Patient Care
Current Alzheimer Research Remediation of Cellular Hypoxic Damage by Pharmacological Agents
Current Pharmaceutical Design Patent Selections
Recent Patents on Biomarkers Enhanced Butyrylcholinesterase Activity may be the Common Link in Triggering Low-Grade Systemic Inflammation and Decrease in Cognitive Function in Diabetes Mellitus and Alzheimers disease
Current Nutrition & Food Science Retromer Dysfunction and Neurodegenerative Disease
Current Genomics The Role of Microglia in Antibody-Mediated Clearance of Amyloid-Beta from the Brain
CNS & Neurological Disorders - Drug Targets Emerging Therapeutic Targets in Regenerative Medicine for the Treatment of Diabetes Mellitus: A Patent Literature Review
Recent Patents on Regenerative Medicine The Promise of Slow Down Ageing May Come from Curcumin
Current Pharmaceutical Design Resistance to Aspirin and Thienopyridines in Diabetes Mellitus and Metabolic Syndrome
Current Vascular Pharmacology Cystatin C in Cerebrovascular Disorders
Current Neurovascular Research Cholinesterases and Cholinesterase Inhibitors
Current Enzyme Inhibition Hypoxia Inducible Factor-1 as a Target for Neurodegenerative Diseases
Current Medicinal Chemistry The Role of EC-IC Bypass in Critical Cerebral Hemodynamics of Different Origin
Current Hypertension Reviews Structure and Mechanism of Action of Tau Aggregation Inhibitors
Current Alzheimer Research